In vivo characterization of the specific
β
Tiziana Rubino; Daniela ViganΓ²; Elisabetta Zagato; Mariaelvina Sala; Daniela Par
π
Article
π
2000
π
John Wiley and Sons
π
English
β 127 KB
π 1 views
To characterize the behavioral and biochemical effects of the cannabinoid CB1 antagonist SR141716A, we injected the compound intraperitoneally (ip) at doses from 0.625 mg/kg to 5 mg/kg in rats. SR141716A per se induced a dose-dependent increase of some behavioral signs such as wet dog and head shake